These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29027583)

  • 1. Changes in circulating cell-free DNA and nucleosomes in patients with exacerbated psoriasis.
    Beranek M; Fiala Z; Kremlacek J; Andrys C; Krejsek J; Hamakova K; Chmelarova M; Palicka V; Borska L
    Arch Dermatol Res; 2017 Dec; 309(10):815-821. PubMed ID: 29027583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between severity of the disease and circulating nucleosomes in psoriasis patients.
    Dilek AR; Dilek N; Saral Y; Yüksel D
    Arch Dermatol Res; 2013 Aug; 305(6):483-7. PubMed ID: 23567920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor necrosis factor-α DNA are elevated in psoriasis.
    Sakamoto R; Sawamura S; Kajihara I; Miyauchi H; Urata K; Otsuka-Maeda S; Kanemaru H; Kanazawa-Yamada S; Honda N; Makino K; Miyashita A; Aoi J; Makino T; Fukushima S; Ihn H
    J Dermatol; 2020 Sep; 47(9):1037-1040. PubMed ID: 32515034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dependence of clinical and laboratory indicators of the level of systemic inflammation in patients with psoriasis of moderate severity with concomitant metabolic syndrome].
    Emchenko IaA
    Georgian Med News; 2014 Nov; (236):43-7. PubMed ID: 25541825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
    Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
    Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of TWEAK in patients with psoriasis vulgaris.
    Bilgiç Ö; Sivrikaya A; Toker A; Ünlü A; Altınyazar C
    Cytokine; 2016 Jan; 77():10-3. PubMed ID: 26499979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
    Ataseven A; Kesli R
    G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum C-reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: Long-term differential effects of biologics.
    Asahina A; Umezawa Y; Yanaba K; Nakagawa H
    J Dermatol; 2016 Jul; 43(7):779-84. PubMed ID: 26704718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is enhanced platelet activation the missing link leading to increased cardiovascular risk in psoriasis?
    Chandrashekar L; Rajappa M; Revathy G; Sundar I; Munisamy M; Ananthanarayanan PH; Thappa DM; Basu D
    Clin Chim Acta; 2015 Jun; 446():181-5. PubMed ID: 25920693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining prognosis in canine sepsis by bedside measurement of cell-free DNA and nucleosomes.
    Letendre JA; Goggs R
    J Vet Emerg Crit Care (San Antonio); 2018 Nov; 28(6):503-511. PubMed ID: 30299568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Yinxieling decoction on PASI, TNF-α and IL-8 in patients with psoriasis vulgaris.
    Dai YJ; Li YY; Zeng HM; Liang XA; Xie ZJ; Zheng ZA; Pan QH; Xing YX
    Asian Pac J Trop Med; 2014 Aug; 7(8):668-670. PubMed ID: 25149384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of TNF-α, IL-12/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity.
    Kyriakou A; Patsatsi A; Vyzantiadis TA; Sotiriadis D
    J Immunol Res; 2014; 2014():467541. PubMed ID: 25759829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Visfatin, Adiponectin, and Tumor Necrosis Factor Alpha (TNF-α) Levels in Patients with Psoriasis and their Correlation with Disease Severity.
    Sereflican B; Goksugur N; Bugdayci G; Polat M; Haydar Parlak A
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):13-9. PubMed ID: 27149125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis.
    Akçali C; Guven EH; Kirtak N; Inaloz HS; Ozgoztasi O; Guvenc U
    J Int Med Res; 2014 Oct; 42(5):1118-22. PubMed ID: 25143337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of interleukin-8, tumor necrosis factor-α and γ-interferon in Egyptian psoriatic patients and correlation with disease severity.
    Abdel-Hamid MF; Aly DG; Saad NE; Emam HM; Ayoub DF
    J Dermatol; 2011 May; 38(5):442-6. PubMed ID: 21352285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis decreases the anti-oxidation and anti-inflammation properties of high-density lipoprotein.
    He L; Qin S; Dang L; Song G; Yao S; Yang N; Li Y
    Biochim Biophys Acta; 2014 Dec; 1841(12):1709-15. PubMed ID: 25240836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept.
    Kanelleas A; Liapi C; Katoulis A; Stavropoulos P; Avgerinou G; Georgala S; Economopoulos T; Stavrianeas NG; Katsambas A
    Clin Exp Dermatol; 2011 Dec; 36(8):845-50. PubMed ID: 21790728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease.
    Lee BT; Ahmed FA; Hamm LL; Teran FJ; Chen CS; Liu Y; Shah K; Rifai N; Batuman V; Simon EE; He J; Chen J
    BMC Nephrol; 2015 May; 16():77. PubMed ID: 26025192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte-derived koebnerisin (S100A15) and psoriasin (S100A7) are systemic mediators of inflammation in psoriasis.
    Batycka-Baran A; Hattinger E; Zwicker S; Summer B; Zack Howard OM; Thomas P; Szepietowski JC; Ruzicka T; Prinz JC; Wolf R
    J Dermatol Sci; 2015 Sep; 79(3):214-21. PubMed ID: 26055798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.